{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T05:17:32Z","timestamp":1740806252779,"version":"3.38.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T00:00:00Z","timestamp":1725753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T00:00:00Z","timestamp":1725753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-024-01487-3","type":"journal-article","created":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T13:02:01Z","timestamp":1725800521000},"page":"573-586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Protective Effect of GnRH Agonist Triptorelin on the Histomorphometric Parameters of the Utero-ovarian Tissue in the Doxorubicin- and Cyclophosphamide-treated Mice"],"prefix":"10.1007","volume":"83","author":[{"given":"Soghra","family":"Bahmanpour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negin","family":"Ameri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nehleh","family":"Zareifard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6805-277X","authenticated-orcid":false,"given":"Fatemeh","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,8]]},"reference":[{"key":"1487_CR1","volume":"12","author":"Y Xie","year":"2022","unstructured":"Xie, Y., Duan, H., Wang, D., Li, H., Jia, J., & Zhang, J., et al. (2022). Gonadotropin-releasing hormone agonist protects ovarian function in young patients with ovarian malignancy undergoing platinum-based chemotherapy: A prospective study. Frontiers in Oncology, 12, 986208.","journal-title":"Frontiers in Oncology"},{"key":"1487_CR2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dmz027","volume":"25","author":"N Spears","year":"2019","unstructured":"Spears, N., Lopes, F., Stefansdottir, A., Rossi, V., De Felici, M., & Anderson, R., et al. (2019). Ovarian damage from chemotherapy and current approaches to its protection. Human Reproduction Update, 25, 673\u2013693.","journal-title":"Human Reproduction Update"},{"key":"1487_CR3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1530\/REP-12-0121","volume":"144","author":"I Ben-Aharon","year":"2012","unstructured":"Ben-Aharon, I., & Shalgi, R. (2012). What lies behind chemotherapy-induced ovarian toxicity? Reproduction, 144, 153\u2013163.","journal-title":"Reproduction"},{"key":"1487_CR4","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","volume":"36","author":"K Oktay","year":"2018","unstructured":"Oktay, K., Harvey, B. E., Partridge, A. H., Quinn, G. P., Reinecke, J., & Taylor, H. S., et al. (2018). Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 36, 1994\u20132001.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"key":"1487_CR5","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.annonc.2020.09.006","volume":"31","author":"M Lambertini","year":"2020","unstructured":"Lambertini, M., Peccatori, F. A., Demeestere, I., Amant, F., Wyns, C., & Stukenborg, J.-B., et al. (2020). Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO clinical practice guidelines. Annals of Oncology, 31, 1664\u20131678.","journal-title":"Annals of Oncology"},{"key":"1487_CR6","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.3390\/ijms22136923","volume":"22","author":"Y Sun","year":"2021","unstructured":"Sun, Y., Liu, Y., Ma, X., & Hu, H. (2021). The influence of cell cycle regulation on chemotherapy. International Journal of Molecular Sciences, 22, 6923.","journal-title":"International Journal of Molecular Sciences"},{"key":"1487_CR7","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1634\/theoncologist.2012-0236","volume":"17","author":"KA Rodriguez-Wallberg","year":"2012","unstructured":"Rodriguez-Wallberg, K. A., & Oktay, K. (2012). Fertility preservation and pregnancy in women with and without BRCA mutation\u2013positive breast cancer. The Oncologist, 17, 1409\u20131417.","journal-title":"The Oncologist"},{"key":"1487_CR8","doi-asserted-by":"crossref","unstructured":"Schmidt, D. et al. (2004) The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance Development, 131, 933\u2013942.","DOI":"10.1242\/dev.00969"},{"key":"1487_CR9","doi-asserted-by":"crossref","first-page":"185ra162","DOI":"10.1126\/scitranslmed.3005402","volume":"5","author":"L Kalich-Philosoph","year":"2013","unstructured":"Kalich-Philosoph, L., Roness, H., Carmely, A., Fishel-Bartal, M., Ligumsky, H., & Paglin, S., et al. (2013). Cyclophosphamide triggers follicle activation and \u201cburnout\u201d; AS101 prevents follicle loss and preserves fertility. Science Translational Medicine, 5, 185ra162\u2013185ra162.","journal-title":"Science Translational Medicine"},{"key":"1487_CR10","doi-asserted-by":"crossref","unstructured":"Guo, Y. et al. (2024) Ovarian microenvironment: challenges and opportunities in protecting against chemotherapy-associated ovarian damage. Human Reproduction Update, 30, 614\u2013647.","DOI":"10.1093\/humupd\/dmae020"},{"key":"1487_CR11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3906\/sag-2005-297","volume":"51","author":"\u015eanli","year":"2021","unstructured":"\u015eanli, Atilgan, C., Kulo\u011flu, R., Pala, T., T\u00fcrk, B. A., & Keser, H. B., et al. (2021). Transient receptor potential melastatin 2 ion channel activity in ovarianhyperstimulation syndrome physiopathology. Turkish Journal of Medical Sciences, 51, 787\u2013795.","journal-title":"Turkish Journal of Medical Sciences"},{"key":"1487_CR12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4274\/tjod.galenos.2023.75336","volume":"20","author":"C \u015eanl\u0131","year":"2023","unstructured":"\u015eanl\u0131, C., At\u0131lgan, R., Kulo\u011flu, T., Pala, \u015e., & \u0130lhan, N. (2023). The investigation of cholinergic receptor muscarinic 1 activity in the rat ovary with induced ovarian hyperstimulation. Turkish Journal of Obstetrics and Gynecology, 20, 53.","journal-title":"Turkish Journal of Obstetrics and Gynecology"},{"key":"1487_CR13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/humupd\/dmz041","volume":"26","author":"MJ Griffiths","year":"2020","unstructured":"Griffiths, M. J., Winship, A. L., & Hutt, K. J. (2020). Do cancer therapies damage the uterus and compromise fertility? Human Reproduction Update, 26, 161\u2013173.","journal-title":"Human Reproduction Update"},{"key":"1487_CR14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/annonc\/mdi251","volume":"16","author":"M Campone","year":"2005","unstructured":"Campone, M., Roche, H., Kerbrat, P., Bonneterre, J., Romestaing, P., & Fargeot, P., et al. (2005). Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group. Annals of Oncology, 16, 1343\u20131351.","journal-title":"Annals of Oncology"},{"key":"1487_CR15","volume":"11","author":"C Hu","year":"2024","unstructured":"Hu, C., Mi, W., Li, F., Zhu, L., Ou, Q., & Li, M., et al. (2024). Optimizing drug combination and mechanism analysis based on risk pathway crosstalk in pan cancer. Scientific Data, 11, 74.","journal-title":"Scientific Data"},{"key":"1487_CR16","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1530\/RAF-22-0020","volume":"3","author":"R Rosario","year":"2022","unstructured":"Rosario, R., Cui, W., & Anderson, R. (2022). Potential ovarian toxicity and infertility risk following targeted anti-cancer therapies. Reprod Fertil, 3, R147\u2013R162. 10.1530.RAF-22-0020.","journal-title":"Reprod Fertil"},{"key":"1487_CR17","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1007\/s10815-023-02945-2","volume":"40","author":"MI Albamonte","year":"2023","unstructured":"Albamonte, M. I., & Vitullo, A. D. (2023). Preservation of fertility in female and male prepubertal patients diagnosed with cancer. Journal of Assisted Reproduction and Genetics, 40, 2755\u20132767.","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"1487_CR18","first-page":"117955811987016","volume":"13","author":"Z Blumenfeld","year":"2019","unstructured":"Blumenfeld, Z. (2019). Fertility preservation using GnRH agonists: rationale, possible mechanisms, and explanation of controversy. Clinical Medicine Insights: Reproductive Health, 13, 1179558119870163.","journal-title":"Clinical Medicine Insights: Reproductive Health"},{"key":"1487_CR19","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1016\/j.fertnstert.2013.07.1480","volume":"100","author":"L Detti","year":"2013","unstructured":"Detti, L., Carter, C., Williams, L., Osborne, S., Martin, D., & Uhlmann, R. (2013). Goserelin fosters bone elongation, but does not prevent ovarian damage, in cyclophosphamide (CTX)-treated pre-pubertal mice. Fertility and Sterility, 100, S172\u2013S173.","journal-title":"Fertility and Sterility"},{"key":"1487_CR20","doi-asserted-by":"crossref","first-page":"e0137164","DOI":"10.1371\/journal.pone.0137164","volume":"10","author":"F Horicks","year":"2015","unstructured":"Horicks, F., Van Den Steen, G., Houben, S., Englert, Y., & Demeestere, I. (2015). Folliculogenesis is not fully inhibited during GnRH analogues treatment in mice challenging their efficiency to preserve the ovarian reserve during chemotherapy in this model. PloS One, 10, e0137164.","journal-title":"PloS One"},{"key":"1487_CR21","doi-asserted-by":"crossref","DOI":"10.1177\/1179558119864584","volume":"13","author":"F Poggio","year":"2019","unstructured":"Poggio, F., Lambertini, M., Bighin, C., Conte, B., Blondeaux, E., & D\u2019Alonzo, A., et al. (2019). Potential mechanisms of ovarian protection with gonadotropin-releasing hormone agonist in breast cancer patients: A review. Clinical Medicine Insights Reproductive Health, 13, 1179558119864584.","journal-title":"Clinical Medicine Insights Reproductive Health"},{"key":"1487_CR22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/09513590.2020.1753033","volume":"37","author":"T Atakul","year":"2021","unstructured":"Atakul, T., Tayyar, A. T., Turan, \u00d6. D., \u00c7elik, S. Y., Y\u0131lmaz, M., & K\u00fc\u00e7\u00fck, M., et al. (2021). An assessment of the protective effect of gonadotropin-releasing hormone agonist and antagonist on bleomycin-induced ovarian toxicity in rats. Gynecological Endocrinology : the official journal of the International Society of Gynecological Endocrinology, 37, 46\u201350.","journal-title":"Gynecological Endocrinology : the official journal of the International Society of Gynecological Endocrinology"},{"key":"1487_CR23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1477-7827-8-20","volume":"8","author":"I Ben-Aharon","year":"2010","unstructured":"Ben-Aharon, I., Bar-Joseph, H., Tzarfaty, G., Kuchinsky, L., Rizel, S., & Stemmer, S. M., et al. (2010). Doxorubicin-induced ovarian toxicity. Reproductive Biology and Endocrinology : RB&E, 8, 20.","journal-title":"Reproductive Biology and Endocrinology : RB&E"},{"key":"1487_CR24","volume":"34","author":"Y Yao","year":"2020","unstructured":"Yao, Y., Xu, Y., & Wang, Y. (2020). Protective roles and mechanisms of rosmarinic acid in cyclophosphamide-induced premature ovarian failure. Journal of Biochemical and Molecular Toxicology, 34, e22591.","journal-title":"Journal of Biochemical and Molecular Toxicology"},{"key":"1487_CR25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2818.1987.tb02837.x","volume":"147","author":"HJ Gundersen","year":"1987","unstructured":"Gundersen, H. J., & Jensen, E. B. (1987). The efficiency of systematic sampling in stereology and its prediction. Journal of Microscopy, 147, 229\u2013263.","journal-title":"Journal of Microscopy"},{"key":"1487_CR26","doi-asserted-by":"crossref","unstructured":"Rafiee, B. et al. (2022) Effects of N-acetylcysteine and metformin treatment on the stereopathological characteristics of uterus and ovary. European Journal of Translational Myology, 32, 10409.","DOI":"10.4081\/ejtm.2022.10409"},{"key":"1487_CR27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2020.101871","volume":"110","author":"M Namavar","year":"2020","unstructured":"Namavar, M., Ghalavandi, M., & Bahmanpour, S. (2020). The effect of glutathione and buserelin on the stereological parameters of the hypothalamus in the cyclophosphamide-treated mice. Journal of Chemical Neuroanatomy, 110, 101871.","journal-title":"Journal of Chemical Neuroanatomy"},{"key":"1487_CR28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2818.1979.tb00149.x","volume":"115","author":"EB Jensen","year":"1979","unstructured":"Jensen, E. B., Gundersen, H. J. G., & \u00d8sterby, R. (1979). Determination of membrane thickness distribution from orthogonal intercepts. Journal of Microscopy, 115, 19\u201333.","journal-title":"Journal of Microscopy"},{"key":"1487_CR29","first-page":"973","volume":"20","author":"P Lohrasbi","year":"2022","unstructured":"Lohrasbi, P., Karbalay-Doust, S., Tabei, S. M. B., Azarpira, N., Alaee, S., & Rafiee, B., et al. (2022). The effects of melatonin and metformin on histological characteristics of the ovary and uterus in letrozole-induced polycystic ovarian syndrome mice: A stereological study. International Journal of Reproductive BioMedicine, 20, 973.","journal-title":"International Journal of Reproductive BioMedicine"},{"key":"1487_CR30","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1200\/JCO.2017.76.3441","volume":"36","author":"W Van Dorp","year":"2018","unstructured":"Van Dorp, W., Haupt, R., Anderson, R. A., Mulder, R. L., Van den Heuvel-Eibrink, M. M., & Van Dulmen-den Broeder, E., et al. (2018). Reproductive function and outcomes in female survivors of childhood, adolescent, and young adult cancer: a review. Journal of Clinical Oncology, 36, 2169.","journal-title":"Journal of Clinical Oncology"},{"key":"1487_CR31","doi-asserted-by":"crossref","unstructured":"Syukri, A. et al. (2022) Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-\u03b1 and VEGF pathway in progressive of cardiovascular damage. Annals of Medicine and Surgery, 76, 103501.","DOI":"10.1016\/j.amsu.2022.103501"},{"key":"1487_CR32","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s13287-022-03012-w","volume":"13","author":"M Liu","year":"2022","unstructured":"Liu, M., Zhang, D., Zhou, X., Duan, J., Hu, Y., & Zhang, W., et al. (2022). Cell-free fat extract improves ovarian function and fertility in mice with premature ovarian insufficiency. Stem Cell Research & Therapy, 13, 320.","journal-title":"Stem Cell Research & Therapy"},{"key":"1487_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-020-00735-3","volume":"13","author":"S Bahmanpour","year":"2020","unstructured":"Bahmanpour, S., Moradiyan, E., Dehghani, F., & Zarei-Fard, N. (2020). Chemoprotective effects of plasma derived from mice of different ages and genders on ovarian failure after cyclophosphamide treatment. Journal of Ovarian Research, 13, 1\u201311.","journal-title":"Journal of Ovarian Research"},{"key":"1487_CR34","doi-asserted-by":"crossref","unstructured":"Anand, U. et al. (2022) Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. 10, 1367\u20131401.","DOI":"10.1016\/j.gendis.2022.02.007"},{"key":"1487_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-024-01459-4","volume":"17","author":"E \u00dcst\u00fcner","year":"2024","unstructured":"\u00dcst\u00fcner, E., Y\u0131ld\u0131r\u0131m, E., Macun, H. C., Ekici, H., \u015eahin, Y., & G\u00fcnc\u00fcm, E., et al. (2024). Ultrasonographic and histopathological investigation of the effect of N-acetylcysteine on doxorubicin-induced ovarian and uterine toxicity in rats. Journal of Ovarian Research, 17, 1\u201312.","journal-title":"Journal of Ovarian Research"},{"key":"1487_CR36","doi-asserted-by":"publisher","unstructured":"Song, Y. et al. (2024) Role of DNA damage response in cyclophosphamide\u2010induced premature ovarian failure in mice. Journal of Obstetrics and Gynaecology Research. https:\/\/doi.org\/10.1111\/jog.16004.","DOI":"10.1111\/jog.16004"},{"key":"1487_CR37","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.3390\/cancers16122288","volume":"16","author":"A Markowska","year":"2024","unstructured":"Markowska, A., Antoszczak, M., Markowska, J., & Huczy\u0144ski, A. (2024). Gynotoxic effects of chemotherapy and potential protective mechanisms. Cancers, 16, 2288.","journal-title":"Cancers"},{"key":"1487_CR38","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/humrep\/dey045","volume":"33","author":"N Pascuali","year":"2018","unstructured":"Pascuali, N., Scotti, L., Di Pietro, M., Oubi\u00f1a, G., Bas, D., & May, M., et al. (2018). Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure. Human Reproduction, 33, 844\u2013859.","journal-title":"Human Reproduction"},{"key":"1487_CR39","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1634\/theoncologist.2015-0044","volume":"20","author":"I Ben-Aharon","year":"2015","unstructured":"Ben-Aharon, I., Granot, T., Meizner, I., Hasky, N., Tobar, A., & Rizel, S., et al. (2015). Long-term follow-up of chemotherapy-induced ovarian failure in young breast cancer patients: the role of vascular toxicity. The Oncologist, 20, 985\u2013991.","journal-title":"The Oncologist"},{"key":"1487_CR40","doi-asserted-by":"crossref","unstructured":"Hao, X. et al. (2019) Ovarian follicle depletion induced by chemotherapy and the investigational stages of potential fertility-protective treatments-A review. International Journal of Molecular Sciences, 20, 4720.","DOI":"10.3390\/ijms20194720"},{"key":"1487_CR41","volume":"14","author":"G Li","year":"2023","unstructured":"Li, G., Gu, J., Zhou, X., Wu, T., Li, X., & Hua, R., et al. (2023). Mitochondrial stress response gene Clpp deficiency impairs oocyte competence and deteriorate cyclophosphamide-induced ovarian damage in young mice. Frontiers in Endocrinology, 14, 1122012.","journal-title":"Frontiers in Endocrinology"},{"key":"1487_CR42","doi-asserted-by":"crossref","unstructured":"Di Emidio, G. et al. (2017) The natural carotenoid crocetin and the synthetic tellurium compound AS101 protect the ovary against cyclophosphamide by modulating SIRT1 and mitochondrial markers. Oxidative medicine and cellular longevity, 2017, 8928604.","DOI":"10.1155\/2017\/8928604"},{"key":"1487_CR43","volume":"476","author":"J Han","year":"2023","unstructured":"Han, J., Wang, S., Wang, H., Zhang, T., Yang, Y., & Zhao, T., et al. (2023). SIRT1 reduction contributes to doxorubicin\u2013induced oxidative stress and meiotic failure in mouse oocytes. Toxicology and Applied Pharmacology, 476, 116671.","journal-title":"Toxicology and Applied Pharmacology"},{"key":"1487_CR44","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.reprotox.2010.07.003","volume":"30","author":"H Bar-Joseph","year":"2010","unstructured":"Bar-Joseph, H., Ben-Aharon, I., Rizel, S., Stemmer, S. M., Tzabari, M., & Shalgi, R. (2010). Doxorubicin-induced apoptosis in germinal vesicle (GV) oocytes. Reproductive Toxicology, 30, 566\u2013572.","journal-title":"Reproductive Toxicology"},{"key":"1487_CR45","doi-asserted-by":"crossref","unstructured":"Kashi, O., & Meirow, D. (2023) Overactivation or apoptosis: which mechanisms affect chemotherapy-induced ovarian reserve depletion? International Journal of Molecular Sciences, 24, 16291.","DOI":"10.3390\/ijms242216291"},{"key":"1487_CR46","doi-asserted-by":"crossref","unstructured":"Roness, H., Gavish, Z., Cohen, Y., & Meirow, D. Ovarian follicle burnout: a universal phenomenon?: Taylor & Francis; 2013. p. 3245\u20133246","DOI":"10.4161\/cc.26358"},{"key":"1487_CR47","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.rbmo.2016.10.005","volume":"34","author":"Y Lande","year":"2017","unstructured":"Lande, Y., Fisch, B., Tsur, A., Farhi, J., Prag-Rosenberg, R., & Ben-Haroush, A., et al. (2017). Short-term exposure of human ovarian follicles to cyclophosphamide metabolites seems to promote follicular activation in vitro. Reproductive Biomedicine Online, 34, 104\u2013114.","journal-title":"Reproductive Biomedicine Online"},{"key":"1487_CR48","first-page":"2926","volume":"30","author":"A Yuksel","year":"2015","unstructured":"Yuksel, A., Bildik, G., Senbabaoglu, F., Akin, N., Arvas, M., & Unal, F., et al. (2015). The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells. Human Reproduction, 30, 2926\u20132935.","journal-title":"Human Reproduction"},{"key":"1487_CR49","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/humupd\/dms022","volume":"18","author":"S Morgan","year":"2012","unstructured":"Morgan, S., Anderson, R., Gourley, C., Wallace, W., & Spears, N. (2012). How do chemotherapeutic agents damage the ovary? Human Reproduction Update, 18, 525\u2013535.","journal-title":"Human Reproduction Update"},{"key":"1487_CR50","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s10815-020-01792-9","volume":"37","author":"D Garg","year":"2020","unstructured":"Garg, D., Johnstone, E., Lomo, L., Fair, D., Rosen, M., & Taylor, R., et al. (2020). Looking beyond the ovary for oncofertility care in women: uterine injury as a potential target for fertility-preserving treatments. Journal of Assisted Reproduction and Genetics, 37, 1467\u20131476.","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"1487_CR51","doi-asserted-by":"crossref","first-page":"251","DOI":"10.6002\/ect.2017.0320","volume":"21","author":"S Tuncer","year":"2018","unstructured":"Tuncer, S., Atilgan, R., Pala, \u015e., Kulo\u011flu, T., Arta\u015f, G., & Ayd\u0131n, S. (2018). N-acetylcysteine and benfotiamine protect autotransplanted ovarian tissue from ischemia-reperfusion injury: An experimental study. Experimental and Clinical Transplantation: Official Journal of the Middle East Society for Organ Transplantation, 21, 251\u2013258.","journal-title":"Experimental and Clinical Transplantation: Official Journal of the Middle East Society for Organ Transplantation"},{"key":"1487_CR52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/jwh.2008.0857","volume":"18","author":"ME Clowse","year":"2009","unstructured":"Clowse, M. E., Behera, M. A., Anders, C. K., Copland, S., Coffman, C. J., & Leppert, P. C., et al. (2009). Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. Journal of Women\u2019s Health (2002), 18, 311\u2013319.","journal-title":"Journal of Women\u2019s Health (2002)"},{"key":"1487_CR53","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0002-9378(12)91826-8","volume":"170","author":"RC Reinsch","year":"1994","unstructured":"Reinsch, R. C., Murphy, A. A., Morales, A. J., & Yen, S. S. (1994). The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study. American Journal of Obstetrics and Gynecology, 170, 1623\u20131628.","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"1487_CR54","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/humrep\/dei166","volume":"20","author":"EHY Ng","year":"2005","unstructured":"Ng, E. H. Y., Tang, O. S., Chan, C. C. W., & Ho, P. C. (2005). Ovarian stromal blood flow in the prediction of ovarian response during in vitro fertilization treatment. Human Reproduction, 20, 3147\u20133151.","journal-title":"Human Reproduction"},{"key":"1487_CR55","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1210\/jc.2006-1147","volume":"91","author":"J-H Choi","year":"2006","unstructured":"Choi, J.-H., Gilks, C. B., Auersperg, N., & Leung, P. C. (2006). Immunolocalization of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and type I GnRH receptor during follicular development in the human ovary. The Journal of Clinical Endocrinology & Metabolism, 91, 4562\u20134570.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"1487_CR56","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000096062","volume":"63","author":"A Imai","year":"2007","unstructured":"Imai, A., Sugiyama, M., Furui, T., Tamaya, T., & Ohno, T. (2007). Direct protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulosa cell damage. Gynecologic and Obstetric Investigation, 63, 102\u2013106.","journal-title":"Gynecologic and Obstetric Investigation"},{"key":"1487_CR57","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.ajpath.2017.03.013","volume":"187","author":"K Kyritsi","year":"2017","unstructured":"Kyritsi, K., Meng, F., Zhou, T., Wu, N., Venter, J., & Francis, H., et al. (2017). Knockdown of hepatic gonadotropin-releasing hormone by vivo-morpholino decreases liver fibrosis in multidrug resistance gene 2 knockout mice by down-regulation of miR-200b. The American Journal of Pathology, 187, 1551\u20131565.","journal-title":"The American Journal of Pathology"},{"key":"1487_CR58","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1080\/14656566.2023.2248890","volume":"24","author":"M Ciebiera","year":"2023","unstructured":"Ciebiera, M., Madueke-Laveaux, O. S., Feduniw, S., Ulin, M., Spaczy\u0144ski, R., & Zgliczy\u0144ska, M., et al. (2023). GnRH agonists and antagonists in therapy of symptomatic uterine fibroids\u2013current roles and future perspectives. Expert Opinion on Pharmacotherapy, 24, 1799\u20131809.","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"1487_CR59","first-page":"e38136","volume":"15","author":"C Resta","year":"2023","unstructured":"Resta, C., Moustogiannis, A., Chatzinikita, E., Malligiannis Ntalianis, D., Malligiannis Ntalianis, K., & Philippou, A., et al. (2023). Gonadotropin-releasing hormone (GnRH)\/GnRH receptors and their role in the treatment of endometriosis. Cureus, 15, e38136.","journal-title":"Cureus"},{"key":"1487_CR60","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1677\/erc.0.0100291","volume":"10","author":"G Emons","year":"2003","unstructured":"Emons, G., Gr, C., Westphalen, S., Kavanagh, J., & Verschraegen, C. (2003). GnRH antagonists in the treatment of gynecological and breast cancers. Endocrine-Related Cancer, 10, 291\u2013299.","journal-title":"Endocrine-Related Cancer"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01487-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-024-01487-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01487-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T06:30:47Z","timestamp":1740724247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-024-01487-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,8]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["1487"],"URL":"https:\/\/doi.org\/10.1007\/s12013-024-01487-3","relation":{},"ISSN":["1559-0283"],"issn-type":[{"type":"electronic","value":"1559-0283"}],"subject":[],"published":{"date-parts":[[2024,9,8]]},"assertion":[{"value":"9 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This experimental procedure was approved by the Ethics Committee of Shiraz University of Medical Sciences (SUMS, Shiraz, Iran, Ethic code: IR.SUMS.AEC.1400.045).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}